Topics
Glioblastoma | Treatment | Targeted therapy | VAL-083 (dianhydrogalactitol; DAG)
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > VAL-083
Guo C, Yang Q, Deng M, Qiu X, Wu S, Du X, Sai K, Dai Z, Chen Z,
Zhang J, Lin F, Ke C, Xi S, Hu W, Zhou Z, Li J, Cao X, Liao Y, Lv
Y, Brown D, Langlands J, Johnson G, Bacha J, Kwan C, Kanekal S,
Schwartz R, Chen Z.
VAL-083 is
effective in patients with newly-diagnosed MGMT-unmethylated
glioblastoma: report of phase II study.
Discov
Oncol. 2025 Dec 12. doi:
10.1007/s12672-025-04235-y. PMID:
41385182. Interventional study. ˍ